Quinolones in Sexually Transmitted Diseases
Author:
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 58 (2) , 92-95
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Sequencing of Gyrase and Topoisomerase IV Quinolone-Resistance-Determining Regions of Chlamydia trachomatis and Characterization of Quinolone-Resistant Mutants Obtained In VitroAntimicrobial Agents and Chemotherapy, 1998
- Gonorrhoea treatment failure and ciprofloxacin resistanceInternational Journal of STD & AIDS, 1998
- In Vitro Activity of BAY 12-8039, a New Fluoroquinolone, against MycoplasmasAntimicrobial Agents and Chemotherapy, 1998
- In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia sppAntimicrobial Agents and Chemotherapy, 1997
- In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolatesJournal of Antimicrobial Chemotherapy, 1997
- Susceptibility of Chlamydia trachomatis to trovafloxacin.Journal of Antimicrobial Chemotherapy, 1997
- Fluoroquinolone Treatment Failure in GonorrheaSexually Transmitted Diseases, 1997
- Oral Clindamycin and Ciprofloxacin Versus Intramuscular Ceftriaxone and Oral Doxycycline in the Treatment of Mild-to-Moderate Pelvic Inflammatory Disease in OutpatientsClinical Infectious Diseases, 1997
- Quinolones in Sexually Transmitted DiseasesDrugs, 1995
- Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection.